Viewing nowCombinationPijet Tablet 4/10mg
Pitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 202301669 · Approved 2023.05.25 · Insurance code 645907450
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps control blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it lowers total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol levels. This medication serves as an adjunct to diet, contributing to the management of blood lipid concentrations and reducing the risk of cardiovascular diseases. Therefore, it is effective in cholesterol management and improving healthy blood fat balance.
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram of pitavastatin calcium is recommended for patients with hepatic impairment, this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended for initial treatment. The maximum dose is 2/10mg daily. Use of this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (a combination of pitavastatin calcium/ezetimibe) to patients with severe hepatic impairment.
This medication should not be used in certain patients. For example, patients with allergies to any of the components of this medication or those with severe liver problems, pregnant or nursing women, and children should not take this medication. Additionally, patients with slightly impaired liver function, those who consume alcohol excessively, patients with renal abnormalities, individuals with muscle diseases, and elderly patients should use this medication cautiously. Various side effects such as myalgia, fatigue, dyspepsia, headache, skin rashes can occur, so patients should consult a doctor immediately if any abnormal symptoms arise. Regular liver function tests should be conducted, and if liver enzyme levels rise, discontinuation of the medication may be necessary. If any abnormal symptoms in muscles (pain, weakness, etc.) occur, treatment should be stopped immediately, and the doctor should be informed. Caution is required as there is a risk of serious muscle damage called rhabdomyolysis. This medication may interact with other drugs, so especially when taking together with cyclosporine, fibrates, niacin, antibiotics, etc., it should be used under professional guidance. Pregnant women or those who could become pregnant should not take this medication, and nursing women should also avoid its use. The safety and efficacy for children have not been confirmed, so it is not used in this age group. Elderly patients are at higher risk for side effects due to diminished bodily functions, so caution is necessary. In cases of overdose, there is no specific antidote, and treatment should be symptom-oriented, managing liver function and muscle enzyme testing.
Abdominal pain, diarrhea, dry mouth, bloating, gastroesophageal reflux disease, toothache, increased blood creatine phosphokinase, increased alanine aminotransferase, increased aspartate aminotransferase, weakness, chest discomfort, fatigue, myalgia, taste disturbance, headache, urticaria, dizziness, decreased appetite, insomnia, dyspnea, constipation, dryness, rash, lethargy, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, increased bilirubin, increased cholinesterase, stiffness, drowsiness, thirst, dyspepsia, abdominal distension, stomatitis, vomiting, poor appetite, glossitis, nausea, gastric discomfort, thrombocytopenia, granulocytopenia, leukopenia, eosinophilia, leukocytosis, elevated globulin, positive Coombs test, anemia, polyuria, elevated BUN, increased serum creatinine, decreased aldosterone, increased aldosterone, elevated adrenocorticotropic hormone, elevated cortisol, decreased testosterone, muscle cramps, elevated myoglobin, palpitations, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, hair loss, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes mellitus, immune-mediated necrotizing myopathy, facial edema, arm edema, hypersensitivity, skin tingling, elevated blood pressure, chest discomfort, upper respiratory tract infection, pharyngitis, sinusitis, cough, arthralgia, low back pain, limb pain, congestive heart failure, myocardial ischemia, flushing, conjunctival congestion, renal failure, abnormal liver function, increased blood creatinine, increased blood urea, abnormal liver function tests, anaphylaxis, erythema multiforme, pancreatitis, cholelithiasis, cholecystitis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is advisable to keep the medication at room temperature in a cool place, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.
Pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 2.205mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 4.409mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ankuk Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ahn Gook Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.